Recombinant DNA Advisory Committee; Notice of Meeting

[Federal Register Volume 64, Number 31 (Wednesday, February 17, 1999)]
[Notices]
[Page 7964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-3850]


      

[[Page 7963]]

_______________________________________________________________________

Part III





Department of Health and Human Services





_______________________________________________________________________



National Institutes of Health



_______________________________________________________________________



Recombinant DNA Advisory Committee and Research; Notice of a Meeting 
and Proposed Actions Under the Guidelines; Notices

Federal Register / Vol. 64, No. 31 / Wednesday, February 17, 1999 / 
Notices

[[Page 7964]]



DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Recombinant DNA Advisory Committee; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee on March 11-12, 1999. The 
meeting will be held at the National Institutes of Health, Building 
31C, 6th Floor, Conference Room 10, 9000 Rockville Pike, Bethesda, 
Maryland 20892, starting on March 11, 1999, at approximately 9 a.m., 
and will recess at approximately 5 p.m. The meeting will reconvene on 
March 12, 1999, at approximately 8:30 a.m. and will adjourn at 
approximately 5 p.m. The meeting will be open to the public, except for 
a portion of the day on March 12. In accordance with sections 
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., the meeting may be closed to 
the public on March 12 from approximately 10:00 a.m. to approximately 
10:30 a.m. for the discussion of a protocol. These discussions could 
disclose trade secrets and commercial property such as patentable 
material and personal information concerning individuals associated 
with the protocols, the disclosure of which would constitute a clearly 
unwarranted invasion of privacy. The meeting will be held to discuss 
Proposed Actions under the NIH Guidelines for Research Involving 
Recombinant DNA Molecules (59 FR 34496, amended 59 FR 40170, 60 FR 
20726, 61 FR 1482, 61 FR 10004, 62 FR 4782, 62 FR 53335, 62 FR 56196, 
62 FR 59032, 63 FR 8052, 63 FR 26018) and other matters to be 
considered by the Committee. The Proposed Actions will follow this 
notice of meeting. Attendance by the public will be limited to space 
available.
    Debra W. Knorr, Acting Director, Office of Recombinant DNA 
Activities, National Institutes of Health, MSC 7010, 6000 Executive 
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide summaries of the meeting and a 
roster of committee members upon request. Individuals who plan to 
attend and need special assistance, such assign language interpretation 
or other reasonable accommodations, should contact Ms. Knorr in advance 
of the meeting. The Office of Recombinant DNA Activities (ORDA) web 
site is located at www.nih.gov/od/orda for further information 
about the office.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
virtually every NIH and Federal research program in which DNA 
recombinant molecule techniques could be used, it has been determined 
not to be cost effective or in the public interest to attempt to list 
these programs. Such a list would likely require several additional 
pages. In addition, NIH could not be certain that every Federal program 
would be included as many Federal agencies, as well as private 
organizations, both national and international, have elected to follow 
the NIH Guidelines. In lieu of the individual program listing, NIH 
invites readers to direct questions to the information address above 
about whether individual programs listed in the Catalog of Federal 
Domestic Assistance are affected.

    Dated: February 8, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, National Institutes of Health.
[FR Doc. 99-3850 Filed 2-16-99; 8:45 am]
BILLING CODE 4140-01-P